PRICE T ROWE ASSOCIATES INC /MD/ - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 73 filers reported holding ACELRX PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$62,000
-53.0%
60,400
-36.9%
0.00%
Q2 2021$132,000
-23.7%
95,700
-5.9%
0.00%
Q1 2021$173,000
+16.1%
101,725
+77.8%
0.00%
Q4 2016$149,000
+156.9%
57,200
+163.4%
0.00%
Q2 2016$58,000
-14.7%
21,718
-1.4%
0.00%
Q1 2016$68,000
-69.8%
22,018
-62.3%
0.00%
Q4 2015$225,000
+5.1%
58,346
+49.8%
0.00%
Q3 2014$214,000
-46.4%
38,9370.0%0.00%
Q2 2014$399,000
-44.4%
38,937
-34.8%
0.00%
Q1 2014$717,00059,7350.00%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Values First Advisors, Inc. 250,110$528,0000.51%
XTX MARKETS LLC 12,925$27,0000.19%
Cornerstone Capital, Inc. 491,560$1,037,0000.15%
Aristides Capital LLC 64,482$136,0000.10%
LINCOLN CAPITAL CORP 57,000$120,0000.09%
HighVista Strategies LLC 41,400$87,0000.07%
Ahrens Investment Partners LLC 61,500$130,0000.05%
J Arnold Wealth Management Co 18,000$38,0000.05%
GSA CAPITAL PARTNERS LLP 114,437$241,0000.03%
Avidian Wealth Solutions, LLC 63,000$133,0000.02%
View complete list of ACELRX PHARMACEUTICALS INC shareholders